{"id":3171,"date":"2023-02-09T08:04:16","date_gmt":"2023-02-08T23:04:16","guid":{"rendered":"https:\/\/www.asahikawa-med.ac.jp\/hospital\/pharmacy\/?page_id=3171"},"modified":"2023-03-09T19:49:19","modified_gmt":"2023-03-09T10:49:19","slug":"2022%e5%b9%b4%e6%a5%ad%e7%b8%be","status":"publish","type":"page","link":"https:\/\/www.asahikawa-med.ac.jp\/hospital\/pharmacy\/2022%e5%b9%b4%e6%a5%ad%e7%b8%be","title":{"rendered":"2022\u5e74 \u696d\u7e3e"},"content":{"rendered":"

\"\"<\/p>\n

2022\u5e74 \u539f\u8457\u8ad6\u6587<\/h4>\n

1. Yoshida K, Kawai M, Utsunomiya T, Ishibazawa A, Song YS, Udo MB, Tasaki Y, Yoshida A. Extracellular matrix gene expression in human trabecular meshwork cells following mechanical fluid flow stimulation. Int J Ophthalmol<\/i>, 2022, 15(3):388-393.<\/h><\/p>\n

 <\/p>\n

2. Chuma M, Nakamoto A, Bando T, Niimura T, Kondo Y, Hamano H, Okada N, Asada M, Zamami Y, Takechi K, Goda M, Miyata K, Yagi K, Yoshioka T, Izawa-Ishizawa Y, Yanagawa H, Tasaki Y, Ishizawa K. Association between statin use and daptomycin-related musculoskeletal adverse events: A mixed approach combining a meta-analysis and a disproportionality analysis. Clin Infect Dis<\/i>, 2022, 75(8):1416-1422.<\/h>
\n <\/p>\n

3. \u795e\u5c71\u76f4\u4e5f, \u7af9\u539f\u6709\u53f2, \u771e\u934b\u8cb4\u884c, \u7530\ufa11\u5609\u4e00, \u677e\u672c\u6210\u53f2. \u30a2\u30ab\u30c7\u30df\u30a2\u304c\u4e3b\u4f53\u3068\u306a\u3063\u3066\u884c\u3046\u6cbb\u9a13\u85ac\u88fd\u9020\u306b\u304a\u3051\u308b\u88fd\u9020\u5c02\u7528\u533b\u85ac\u54c1\u306e\u8cfc\u5165 \uff5e\u85ac\u6a5f\u6cd5\u65bd\u884c\u898f\u5247\u7b2c138\u6761\u306b\u95a2\u3059\u308b\u5c40\u9577\u901a\u77e5\u306e\u89e3\u91c8\u306b\u3064\u3044\u3066\uff5e. \u81e8\u5e8a\u85ac\u7406, 2022, 53(2):27-34.<\/h><\/p>\n

 <\/p>\n

4\uff0e\u4e45\u4fdd\u9756\u61b2, \u677e\u91ce\u76f4\u5f92, \u4e2d\u5ddd\u76f4\u6a39, \u5185\u7530\u5927\u8cb4, \u7389\u6728\u5cb3, \u9ad8\u6a4b\u88d5\u4e4b, \u9ed2\u5742\u53cb\u91cc\u6075, \u5b89\u85e4\u4f38, \u8c37\u91ce\u7f8e\u667a\u679d, \u67ff\u5d0e\u79c0\u5b8f, \u6a2a\u5c3e\u82f1\u6a39, \u6771\u4fe1\u826f, \u7530\ufa11\u5609\u4e00\uff0eTacrolimus\u5f90\u653e\u88fd\u5264\u3092\u670d\u7528\u4e2d\u306b\u814e\u6bd2\u6027\u3092\u793a\u3057\u305f\u814e\u79fb\u690d\u75c7\u4f8b\u306b\u304a\u3051\u308bCYP3A5\u907a\u4f1d\u5b50*1 allele\u3068\u80a5\u6e80\u30b5\u30eb\u30b3\u30da\u30cb\u30a2\u306e\u610f\u7fa9\uff0e\u79fb\u690d 57(2), 177-182, 2022\uff0e<\/h><\/p>\n

 <\/p>\n

5\uff0e\u5927\u6edd\u5eb7\u4e00\uff0c\u6ff1\u307f\u3086\u304d\uff0c\u9ad8\u7530\u7fd4\u548c\uff0c\u5ca9\u5c71\u8a13\u5178\uff0c\u7530\ufa11\u5609\u4e00\uff0e\u30a2\u30f3\u30b1\u30fc\u30c8\u3092\u7528\u3044\u305f\u5e02\u4e2d\u6b6f\u79d1\u533b\u5e2b\u306e\u85ac\u5264\u8010\u6027\u5bfe\u7b56\u30a2\u30af\u30b7\u30e7\u30f3\u30d7\u30e9\u30f3\u8a8d\u77e5\u5ea6\u306b\u3088\u308b\u5185\u670d\u6297\u83cc\u85ac\u306e\u4f7f\u7528\u52d5\u5411\u3068\u85ac\u5264\u5e2b\u3068\u306e\u304b\u304b\u308f\u308a\u306b\u5bfe\u3059\u308b\u5b9f\u614b\u8abf\u67fb\uff0e\u533b\u7642\u85ac\u5b66 48(7), 292-301, 2022\uff0e<\/h><\/p>\n

 <\/p>\n

6. Chuma M, Hamano H, Bando T, Kondo M, Okada N, Izumi Y, Ishida S, Yoshioka T, Asada M, Niimura T, Zamami Y, Takechi K, Goda M, Miyata K, Yagi K, Kasamo S, Izawa-Ishizawa Y, Azuma M, Yanagawa H, Tasaki Y, Keisuke Ishizawa K. Non-recovery of vancomycin-associated nephrotoxicity is related to worsening survival outcomes\u2014combined retrospective analyses of two real-world databases. Basic Clin Pharmacol Toxicol<\/i>, 2022, 131:525-535.<\/h><\/p>\n

 <\/p>\n

7. \u7530\ufa11\u5609\u4e00, \u7b2c\uff15\u56de\u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u3000\u5317\u6d77\u9053\u30fb\u6771\u5317\u5730\u65b9\u4f1a\u3092\u958b\u50ac\u3057\u3066, \u81e8\u5e8a\u85ac\u740653(5): 193-195, 2022.<\/h>
\n 
\n8. \u5c71\u7530\u5cfb\u53f2\uff0c\u771e\u934b\u8cb4\u884c\uff0c\u4e39\u4fdd\u4e9c\u5e0c\u4ec1\uff0c\u83c5\u8c37\u9999\u7dd2\u91cc\uff0c\u7530\u539f\u514b\u5bff\uff0c\u5c71\u4e0b\u606d\u7bc4\uff0c\u4e2d\u99ac\u771f\u5e78\uff0c\u7530\ufa11\u5609\u4e00\uff0e\u75c5\u68df\u5e38\u99d0\u85ac\u5264\u5e2b\u306b\u3088\u308b\u30ea\u30b3\u30f3\u30d3\u30ca\u30f3\u30c8\u30fb\u30c8\u30ed\u30f3\u30dc\u30e2\u30c7\u30e5\u30ea\u30f3\u306e\u9069\u6b63\u4f7f\u7528\u63a8\u9032\u3068\u611f\u67d3\u75c7\u6027DIC\u96e2\u8131\u7387\u306e\u6539\u5584. \u533b\u7642\u85ac\u5b66 48(11)\uff0c481-490\uff0c2022.<\/h>
\n <\/p>\n

2022\u5e74 \u8457\u66f8\u30fb\u7dcf\u8aac<\/h3>\n

1. \u4e2d\u99ac\u771f\u5e78, \u7530\ufa11\u5609\u4e00, \u814e\u6a5f\u80fd\u306e\u8a55\u4fa1, \u85ac\u4e8b 64(7): 1332-1335, 2022.<\/h>
\n <\/p>\n

2. \u7530\ufa11\u5609\u4e00, \u8a18\u61b6\u3088\u308a\u8a18\u9332\u3000\u7acb\u3061\u4e0a\u304c\u308c\uff01\u4ee4\u548c\u306e\u85ac\u5264\u5e2b, \u85ac\u5c4073(1):12-13, 2022.<\/h><\/p>\n

 <\/p>\n

3. \u4ef2\u8c37\u5f70\u898f, \u5c71\u7530\u5cfb\u53f2, \u30b7\u30fc\u30e0\u30ec\u30b9\u306a\u7642\u990a\u652f\u63f4\u306b\u3064\u306a\u304c\u308b\u300c\u9000\u9662\u6642\u6307\u5c0e\u8a18\u9332\u300d\u300c\u85ac\u5264\u7ba1\u7406\u30b5\u30de\u30ea\u30fc\u300d\u306e\u66f8\u304d\u65b9, \u85ac\u5c4073(1):56-60, 2022.<\/h><\/p>\n

 <\/p>\n

4. \u77f3\u5ddd\u826f\u592a, \u30ef\u30eb\u30d5\u30a1\u30ea\u30f3 \u5fc3\u81d3\u5f01\u7f6e\u63db\u8853\u5f8c\u306e\u7ba1\u7406\uff0cPT-INR\u306e\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0, \u85ac\u4e8b64(10):59-66, 2022.<\/h><\/p>\n

 <\/p>\n

5. \u677e\u6d66\u6cf0\u5bdb, \u30ec\u30d9\u30c1\u30e9\u30bb\u30bf\u30e0\uff0c\u30e9\u30e2\u30c8\u30ea\u30ae\u30f3\uff0c\u30da\u30e9\u30f3\u30d1\u30cd\u30eb\uff0c\u30e9\u30b3\u30b5\u30df\u30c9 \u65b0\u4e16\u4ee3\u6297\u3066\u3093\u304b\u3093\u85ac\u306e\u8840\u4e2d\u6fc3\u5ea6\u30fb\u6295\u4e0e\u91cf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8, \u85ac\u4e8b64(10):180-187, 2022.<\/h><\/p>\n

 <\/p>\n

6. \u6afb\u5ead\u597d\u7950, \u6ce8\u5c04\u7528\u30ab\u30ea\u30a6\u30e0\u88fd\u5264 \u96fb\u89e3\u8cea\u7570\u5e38\u3078\u306e\u6295\u4e0e\u3068\u8aa4\u6295\u4e0e\u9632\u6b62\u5bfe\u7b56, \u85ac\u4e8b64(10):285-291, 2022.<\/h><\/p>\n

 
\n7. \u5409\u7530\u5149\u4e00, \u9ad8\u5d0e\u82f1\u6c17, \u4e2d\u99ac\u771f\u5e78, \u7530\ufa11\u5609\u4e00, \u9045\u767a\u6027\u30b8\u30b9\u30ad\u30cd\u30b8\u30a2\u3092\u767a\u75c7\u3057\u305f\u591a\u5264\u4f75\u7528\u60a3\u8005\u306e\u51e6\u65b9\u306b\u4ecb\u5165\u3057\u75c7\u72b6\u304c\u8efd\u5feb\u3057\u305f1\u4f8b, \u5317\u6d77\u9053\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\u8a8c103\u53f7:5-9, 2022.<\/h>
\n <\/p>\n

2022\u5e74 \u5b66\u4f1a\u767a\u8868<\/h3>\n

1. \u5c71\u672c\u8b72. \u30a8\u30f3\u30bf\u30ab\u30dd\u30f3\u4f75\u7528\u4e0b\u306b\u304a\u3051\u308bL-dopa\u304a\u3088\u3073\u305d\u306e\u4ee3\u8b1d\u7269\u3067\u3042\u308b3-OMD\u306e\u4f53\u5185\u52d5\u614b\u306b\u53ca\u307c\u3059COMT Val158Met\u907a\u4f1d\u5b50\u591a\u578b\u306e\u5f71\u97ff. Postdoctoral Award\u53d7\u8cde\u8b1b\u6f14(2022\u5e74). \u7b2c32\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a, 2022.<\/h><\/p>\n

 <\/p>\n

2. \u90fd\u7bc9\u4ec1\u7f8e, \u4e2d\u99ac\u771f\u5e78, \u5bfa\u5ddd\u592e\u4e00, \u5bd2\u85e4\u96c5\u4fca, \u5ca9\u5c71\u8a13\u5178, \u5c71\u672c\u8b72, \u4e45\u4fdd\u9756\u61b2, \u795e\u5c71\u76f4\u4e5f, \u771e\u934b\u8cb4\u884c, \u7530\ufa11\u5609\u4e00, \u5c0f\u5150\u306b\u304a\u3051\u308b\u30a2\u30eb\u30d9\u30ab\u30b7\u30f3\u306e\u4f53\u5185\u52d5\u614b\u306b\u767a\u71b1\u6027\u597d\u4e2d\u7403\u6e1b\u5c11\u75c7\u304c\u53ca\u307c\u3059\u5f71\u97ff\u306b\u3064\u3044\u3066. \u7b2c32\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a, 2022.<\/h><\/p>\n

 <\/p>\n

3. \u677e\u6d66\u6cf0\u5bdb, \u771e\u934b\u8cb4\u884c, \u65b0\u7530\u60a0\u4e00\u6717, \u77f3\u5ddd\u826f\u592a, \u4ef2\u8c37\u5f70\u898f, \u4e45\u4fdd\u9756\u61b2, \u5c71\u672c\u8b72, \u5ca9\u5c71\u8a13\u5178, \u795e\u5c71\u76f4\u4e5f, \u4e2d\u99ac\u771f\u5e78, \u5c0f\u91ce\u5c1a\u5fd7, \u7530\ufa11\u5609\u4e00, \u30d0\u30a4\u30a2\u30eb\u88fd\u5264\u306e\u5206\u5272\u4f7f\u7528\u3092\u76ee\u6307\u3057\u305f\u6a21\u64ec\u30d0\u30a4\u30a2\u30eb\u3092\u7528\u3044\u305f\u9577\u671f\u7121\u83cc\u6027\u4fdd\u6301\u6761\u4ef6\u306e\u691c\u8a0e. \u7b2c32\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a, 2022.<\/h><\/p>\n

 <\/p>\n

4. \u7530\ufa11\u5609\u4e00. \u8ad6\u6587\u4f5c\u6210\u306b\u3082\u5f79\u7acb\u3064\u67fb\u8aad\u30fb\u8ad6\u6587\u5be9\u67fb\u306e\u30dd\u30a4\u30f3\u30c8. \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, \u7b2c32\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a, 2022.<\/h><\/p>\n

 <\/p>\n

5. Chuma M, Nakamoto A, Bando T, Niimura T, Kondo Y, Hamano H, Okada N, Asada M, Zamami Y, Takechi K, Goda M, Miyata K, Yagi K, Yoshioka T, Izawa-Ishizawa Y, Yanagawa H, Ishizawa K, Tasaki Y. Association between statin use and daptomycin-related musculoskeletal adverse events. International Symposium, The 32nd Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences, 2022.<\/h><\/p>\n

 <\/p>\n

6. \u4e45\u4fdd\u9756\u61b2, \u5c71\u672c\u8b72, \u771e\u934b\u8cb4\u884c, \u4e2d\u99ac\u771f\u5e78, \u9ad9\u6a4b\u88d5\u4e4b, \u5185\u7530\u5927\u8cb4, \u4eca\u4e95\u6d69\u4e8c, \u677e\u91ce\u76f4\u5f92, \u6a2a\u5c3e\u82f1\u6a39, \u7530\ufa11\u5609\u4e00. \u814e\u79fb\u690d\u60a3\u8005\u306b\u304a\u3051\u308b\u30bf\u30af\u30ed\u30ea\u30e0\u30b9\u8840\u4e2d\u6fc3\u5ea6\u3068\u4f53\u7d44\u6210\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u7b2c58\u56de\u65e5\u672c\u79fb\u690d\u5b66\u4f1a\u7dcf\u4f1a, 2022.<\/h>
\n 
\n7. \u98ef\u7530\u614e\u4e5f, \u5ca9\u7530\u9054\u4e5f, \u592a\u7530\u4e00\u7f8e, \u6e05\u6c34\u7531\u7f8e\u5b50, \u6797\u9054\u54c9, \u7530\ufa11\u5609\u4e00, \u85e4\u8c37\u5e79\u6d69. \u85ac\u5264\u5e2b\u306b\u3088\u308b\u7591\u7fa9\u7167\u4f1a\u60c5\u5831\u306e\u9662\u5185\u5171\u6709\u3068\u51e6\u65b9\u9069\u6b63\u5316\u3078\u306e\u53d6\u308a\u7d44\u307f, \u7b2c17\u56de\u533b\u7642\u306e\u8cea\u30fb\u5b89\u5168\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a,2022.<\/h>
\n 
\n8. \u4e2d\u99ac\u771f\u5e78, \u6ff1\u91ce\u88d5\u7ae0, \u5742\u6771\u8cb4\u53f8, \u65b0\u6751\u8cb4\u535a, \u5ca1\u7530\u76f4\u4eba, \u7b20\u8302\u7d17\u5343\u5b50, \u516b\u6728\u5065\u592a, \u5408\u7530\u5149\u5bdb, \u5ea7\u9593\u5473\u7fa9\u4eba, \u694a\u6cb3\u5b8f\u7ae0, \u77f3\u6fa4\u5553\u4ecb, \u7530\ufa11\u5609\u4e00. \u30d0\u30f3\u30b3\u30de\u30a4\u30b7\u30f3\u95a2\u9023\u814e\u969c\u5bb3\u767a\u75c7\u5f8c\u306e\u814e\u969c\u5bb3\u9077\u5ef6\u306f\u3001\u751f\u547d\u4e88\u5f8c\u3092\u60aa\u5316\u3055\u305b\u308b \u2015 2\u7a2e\u985e\u306e\u30ea\u30a2\u30eb\u30ef\u30fc\u30eb\u30c9\u30c7\u30fc\u30bf\u3092\u7528\u3044\u305f\u878d\u5408\u89e3\u6790 \u2015. \u7b2c96\u56de\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u5e74\u4f1a \/ \u7b2c43\u56de\u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a, 2022.<\/h><\/p>\n

2022\u5e74 \u53d7\u8cde<\/h4>\n

1. \u5c71\u672c\u8b72. 2022\u5e74\u5ea6 \u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a Postdoctoral Award\u8cde.\u300c\u30a8\u30f3\u30bf\u30ab\u30dd\u30f3\u4f75\u7528\u4e0b\u306b\u304a\u3051\u308bL-dopa\u304a\u3088\u3073\u305d\u306e\u4ee3\u8b1d\u7269\u3067\u3042\u308b3-O-\u30e1\u30c1\u30eb\u30c9\u30d1\u306e\u4f53\u5185\u52d5\u614b\u306b\u53ca\u307c\u3059\u30ab\u30c6\u30b3\u30fc\u30eb-O-\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bcVal158Met\u907a\u4f1d\u5b50\u591a\u578b\u306e\u5f71\u97ff\u300d<\/h><\/p>\n

 <\/p>\n

2. \u7530\ufa11\u5609\u4e00. \u4ee4\u548c4\u5e748\u6708\u3000\u65ed\u5ddd\u5e02\u5e02\u653f100\u5e74\u8a18\u5ff5\u5f0f\u5178\u3000\u4fdd\u5065\u798f\u7949\u30fb\u885b\u751f\u529f\u52b4<\/h>
\n <\/p>\n

\u30da\u30fc\u30b8\u30c8\u30c3\u30d7\u3078\u623b\u308b<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

2022\u5e74 \u539f\u8457\u8ad6\u6587 1. Yoshida K, Kawai M, Utsunomiya T, Ishibazawa A, Song YS, Udo MB, Tasaki Y, Yoshida A. Extracellu […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"vkexunit_cta_each_option":"","footnotes":""},"class_list":["post-3171","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.asahikawa-med.ac.jp\/hospital\/pharmacy\/wp-json\/wp\/v2\/pages\/3171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.asahikawa-med.ac.jp\/hospital\/pharmacy\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.asahikawa-med.ac.jp\/hospital\/pharmacy\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.asahikawa-med.ac.jp\/hospital\/pharmacy\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.asahikawa-med.ac.jp\/hospital\/pharmacy\/wp-json\/wp\/v2\/comments?post=3171"}],"version-history":[{"count":28,"href":"https:\/\/www.asahikawa-med.ac.jp\/hospital\/pharmacy\/wp-json\/wp\/v2\/pages\/3171\/revisions"}],"predecessor-version":[{"id":3653,"href":"https:\/\/www.asahikawa-med.ac.jp\/hospital\/pharmacy\/wp-json\/wp\/v2\/pages\/3171\/revisions\/3653"}],"wp:attachment":[{"href":"https:\/\/www.asahikawa-med.ac.jp\/hospital\/pharmacy\/wp-json\/wp\/v2\/media?parent=3171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}